Related references
Note: Only part of the references are listed.Extracellular Vesicles and Cancer: A Focus on Metabolism, Cytokines, and Immunity
Donatella Lucchetti et al.
CANCERS (2020)
Evolution of RAS Mutational Status in Liquid Biopsies During First-Line Chemotherapy for Metastatic Colorectal Cancer
Susanne Klein-Scory et al.
FRONTIERS IN ONCOLOGY (2020)
Exosomes: A Source for New and Old Biomarkers in Cancer
Mariantonia Logozzi et al.
CANCERS (2020)
Progress in exosome associated tumor markers and their detection methods
Mengjiao Shen et al.
MOLECULAR BIOMEDICINE (2020)
Extracellular Vesicles in Oncology: Progress and Pitfalls in the Methods of Isolation and Analysis
Donatella Lucchetti et al.
BIOTECHNOLOGY JOURNAL (2019)
Extracellular Vesicles in Oncology: Progress and Pitfalls in the Methods of Isolation and Analysis
Donatella Lucchetti et al.
BIOTECHNOLOGY JOURNAL (2019)
Liquid Biopsy: Is There an Advantage to Analyzing Circulating Exosomal DNA Compared to cfDNA or Are They the Same?
Christoph Kahlert
CANCER RESEARCH (2019)
Circulating Nucleic Acids Are Associated With Outcomes of Patients With Pancreatic Cancer
Vincent Bernard et al.
GASTROENTEROLOGY (2019)
Transient Disappearance of RAS Mutant Clones in Plasma: A Counterintuitive Clinical Use of EGFR Inhibitors in RAS Mutant Metastatic Colorectal Cancer
Cristina Raimondi et al.
CANCERS (2019)
Protein Profiling and Sizing of Extracellular Vesicles from Colorectal Cancer Patients via Flow Cytometry
Ye Tian et al.
ACS NANO (2018)
Parallel Evaluation of Circulating Tumor DNA and Circulating Tumor Cells in Metastatic Colorectal Cancer
Giovanni Germano et al.
CLINICAL COLORECTAL CANCER (2018)
Enhanced detection of circulating tumor DNA by fragment size analysis
Florent Mouliere et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Liquid Biopsies Using Plasma Exosomal Nucleic Acids and Plasma Cell- Free DNA Compared with Clinical Outcomes of Patients with Advanced Cancers
Lino Moehrmann et al.
CLINICAL CANCER RESEARCH (2018)
Exosome levels in human body fluids: A tumor marker by themselves?
Francesco Cappello et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
Blood-based detection of RAS mutations to guide anti-EGFR therapy in colorectal cancer patients: concordance of results from circulating tumor DNA and tissue-based RAS testing
Wolff Schmiegel et al.
MOLECULAR ONCOLOGY (2017)
New evidence that a large proportion of human blood plasma cell-free DNA is localized in exosomes
M. Rohan Fernando et al.
PLOS ONE (2017)
Classifying the evolutionary and ecological features of neoplasms
Carlo C. Maley et al.
NATURE REVIEWS CANCER (2017)
Differentiation Affects the Release of Exosomes from Colon Cancer Cells and Their Ability to Modulate the Behavior of Recipient Cells
Donatella Lucchetti et al.
AMERICAN JOURNAL OF PATHOLOGY (2017)
High prevalence of mutant KRAS in circulating exosome-derived DNA from early-stage pancreatic cancer patients
K. Allenson et al.
ANNALS OF ONCOLOGY (2017)
Cancer Statistics, 2015
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients
Giulia Siravegna et al.
NATURE MEDICINE (2015)
Identification of Double-stranded Genomic DNA Spanning All Chromosomes with Mutated KRAS and p53 DNA in the Serum Exosomes of Patients with Pancreatic Cancer
Christoph Kahlert et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Resistance to Anti-EGFR Therapy in Colorectal Cancer: From Heterogeneity to Convergent Evolution
Sandra Misale et al.
CANCER DISCOVERY (2014)
Detailed Pathologic Characteristics of the Primary Colorectal Tumor Independently Predict Outcome after Hepatectomy for Metastases
Kenneth Cardona et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
Cancer drug resistance: an evolving paradigm
Caitriona Holohan et al.
NATURE REVIEWS CANCER (2013)
Heterogeneity of KRAS Status May Explain the Subset of Discordant KRAS Status Between Primary and Metastatic Colorectal Cancer
Toshiaki Watanabe et al.
DISEASES OF THE COLON & RECTUM (2011)
被撤回的出版物: MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer (Retracted article. See vol. 175, pg. 192, 2023)
Douglas D. Taylor et al.
GYNECOLOGIC ONCOLOGY (2008)
A population-based study of the incidence, management and prognosis of hepatic metastases from colorectal cancer
J Leporrier et al.
BRITISH JOURNAL OF SURGERY (2006)
Share Paper
